Lisata Therapeutics, Inc.

This study tested a new drug called LSTA1 added to standard treatment for people with advanced bile duct or gallbladder cancer. The goal was to see if the combination is safe and works better than standard treatment alone. The trial was stopped early, and results are not yet avai…

This phase 2 study tested whether a single infusion of a patient's own blood stem cells (CLBS16) could ease chest pain in people with coronary microvascular dysfunction, a condition where the heart's tiny blood vessels don't work properly. The trial enrolled 34 adults with freque…